Skip to main content
OpenTrials
Completed

NCT Number: NCT06332768

NIV Versus HFO Versus Standard Therapy Immediately After Weaning From Mechanical Ventilation in ARDS Patients

The weaning failure is a paramount challenge when aggressive discontinuation of respiratory support in ARDS. The aim of the study is to improve weaning safety and efficacy by a transient postextubation non-invasive respiratory support.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

City hospital # 1

Arkhangelsk, Arkhangelskaya oblast, 163000, Russia

About this study

HFNO (high-flow nasal oxygenation and NIV (non invasive ventilation) are to be randomly compared in the ARDS postextubation period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

ARDS

Exclusion criteria

Severe ICU-aquired weakness Severe COPD

Treatment and study plan

respiratory support

Device

High-flow nasal oxygenation

Other names: Oxygenation

Primary outcomes

  1. Weaning failure

    Time frame: 48 hrs

    Weaning failure and re-intubation or recanulation

Sponsors and collaborators

Lead sponsor

Northern State Medical University

Other

Registry information

Official study title

Comparison of High Flow Oxygenation, Noninvasive Ventilation and Standard Oxygen Therapy in the Early Post-extubation Period in Patients With Acute Respiratory Distress Syndrome

Important dates

Study start
2017
Primary completion
2022
Study completion
2022
First posted
Mar 27, 2024
Registry last updated
Mar 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.